Which immunotherapy do you feel holds the most promise for the treatment of NSCLC? (poll 9069935)

Which immunotherapy do you feel holds the most promise for the treatment of NSCLC?

Atezolizumab (MPDL3280A, Genentech/Roche)

MEDI4726 (MedImmune, AstraZeneca)

Nivolumab (Opdivo, Bristol-Myers Squibb)

Pembrolizumab (Keytruda, Merck)

Submit View Results

See this poll on: https://poll.fm/9069935/embed